DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,000 | -85.7% | 2,723 | -82.7% | 0.00% | – |
| Q3 2019 | $77,000 | -16.3% | 15,707 | +4.2% | 0.00% | – |
| Q2 2019 | $92,000 | +1050.0% | 15,081 | +1008.9% | 0.00% | – |
| Q1 2019 | $8,000 | -60.0% | 1,360 | -8.4% | 0.00% | – |
| Q4 2018 | $20,000 | -37.5% | 1,484 | -9.8% | 0.00% | – |
| Q3 2018 | $32,000 | -34.7% | 1,646 | -14.1% | 0.00% | – |
| Q2 2018 | $49,000 | +48.5% | 1,917 | +15.3% | 0.00% | – |
| Q1 2018 | $33,000 | -53.5% | 1,662 | -52.9% | 0.00% | – |
| Q4 2017 | $71,000 | +115.2% | 3,526 | +118.2% | 0.00% | – |
| Q3 2017 | $33,000 | +175.0% | 1,616 | +106.9% | 0.00% | – |
| Q2 2017 | $12,000 | -99.3% | 781 | -99.2% | 0.00% | -100.0% |
| Q1 2017 | $1,647,000 | +280.4% | 103,257 | +200.0% | 0.01% | +400.0% |
| Q4 2016 | $433,000 | -97.3% | 34,416 | -92.5% | 0.00% | -97.9% |
| Q2 2016 | $15,971,000 | -30.4% | 456,300 | -45.5% | 0.05% | -33.8% |
| Q1 2016 | $22,939,000 | -35.9% | 837,203 | -20.0% | 0.07% | -37.2% |
| Q4 2015 | $35,811,000 | +19.2% | 1,046,480 | +0.1% | 0.11% | +16.5% |
| Q3 2015 | $30,046,000 | -45.1% | 1,045,800 | -14.5% | 0.10% | -40.9% |
| Q2 2015 | $54,738,000 | +19.7% | 1,223,200 | -7.5% | 0.16% | +18.0% |
| Q1 2015 | $45,718,000 | +223.2% | 1,322,100 | +155.8% | 0.14% | +215.9% |
| Q4 2014 | $14,144,000 | – | 516,760 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|